Peoples Bank Abb Vie Inc. Transaction History

Peoples Bank

$192 Million
Q2 2024

A detailed history of Peoples Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Peoples Bank holds 4,058 shares of ABBV stock, worth $785,304. This represents 0.36% of its overall portfolio holdings.

Number of Shares

4,058

Previous 3,609 12.44%

Holding current value

$785,304

Previous $657,000 5.94%

% of portfolio

0.36%

Previous 0.37%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $69,500 - $81,161	449 Added 12.44%	4,058 $696,000
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $27,009 - $30,774	169 Added 4.91%	3,609 $657,000
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $25,593 - $28,824	-186 Reduced 5.13%	3,440 $533,000
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $7,881 - $9,124	59 Added 1.65%	3,626 $540,000
Q2 2023 Jul 28, 2023	BUY	$132.51 - $164.9 $55,256 - $68,763	417 Added 13.24%	3,567 $480,000
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $35,140 - $40,469	-243 Reduced 7.16%	3,150 $502,000
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $130,841 - $156,913	946 Added 38.66%	3,393 $548,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $18,923 - $21,704	-141 Reduced 5.45%	2,447 $328,000
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $2,064 - $2,624	-15 Reduced 0.58%	2,588 $396,000
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $55,695 - $69,102	422 Added 19.35%	2,603 $422,000
Q4 2021 Jan 27, 2022	SELL	$107.43 - $135.93 $5,908 - $7,476	-55 Reduced 2.46%	2,181 $295,000
Q3 2021 Oct 27, 2021	SELL	$106.4 - $120.78 $1,064 - $1,207	-10 Reduced 0.45%	2,236 $242,000
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $236,301 - $263,253	2,246 New	2,246 $253,000
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $240,133 - $306,946	-3,655 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $30,856 - $36,316	-400 Reduced 9.86%	3,655 $295,000
Q4 2018 Feb 26, 2019	BUY	$77.85 - $96.01 $64,615 - $79,688	830 Added 25.74%	4,055 $374,000
Q3 2018 Oct 31, 2018	SELL	$88.91 - $98.84 $6,223 - $6,918	-70 Reduced 2.12%	3,225 $305,000
Q2 2018 Jul 27, 2018	SELL	$89.78 - $106.23 $57,279 - $67,774	-638 Reduced 16.22%	3,295 $305,000
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $29,903 - $40,043	325 Added 9.01%	3,933 $372,000
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $34,301 - $37,614	383 Added 11.88%	3,608 $349,000
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $225,266 - $287,734	3,225	3,225 $287,000

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Bank , based on Form 13F filings with the SEC.

News

Stay updated on Peoples Bank with notifications on news.

Account